BioSearch Inks Oligo Supply, License Deal with IMDx | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – BioSearch Technologies today said that it has licensed patents covering oligonucleotide components to Intelligent Medical Devices (IMDx).

According to the Novato, Calif.-based firm, it has licensed to IMDx access to patents covering its BHQ, CAL Fluor, and Quasar technologies. It also will manufacture cGMP oligonucleotides for Cambridge, Mass.-based IMDx for human in vitro diagnostic use.

Financial and other terms of the alliance were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.